ÂÜÀòÂÒÂ×

Kevin leads the Life Sciences Practice and serves in a CFO role for the clients. With over 20 years of experience in public and private life science companies and professional services. He utilizes his experiences to assist companies in the preparation and completion of financial raises, public company readiness, financial controls, audits, SEC reporting and supporting financial operations from drug development through pharmaceutical product launches.

Kevin’s professional career began in Big 4 public accounting. He has held leadership positions at public biotech companies and private early-stage drug development companies. Kevin has numerous experiences in assisting companies going public at Enumeral, Tesaro, Tetraphase, Karyopharm, and Genocea. Kevin earned a B.S. in business management from the University of Hartford, an MBA from Boston University, and an M.A. in accounting from Suffolk University. Kevin is a CPA in Massachusetts.